Citations

Clear

15 citation(s) found for "Chan, Jason".

SUN-092 Distinct Changes in Gut Microbiota Are Associated with Estradiol-Mediated Protection from Diet-Induced Obesity in Female Mice
Graham, Madeline , Noh, Hye Lim, Suk, Sujin, Friedline, Randall H. , Kim, Jason , Acharya, Kalpana D. , Chen, Jun , Tetel, Marc J.

Mayo Clinic

Journal of the Endocrine Society | May 10, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-sun-092 Get It

Advances in multidisciplinary therapy for meningiomas
Brastianos, Priscilla K. , Butowski, Nicholas , Chan, Jason W., Dunn, Ian F. , Goldbrunner, Roland , Ippen, Franziska M. , Mawrin, Christian , Sloan, Andrew E. , Snyder, James , Tabatabai, Ghazaleh , Tatagiba, Marcos, Wen, Patrick Y. , Aldape, Kenneth, Nassiri, Farshad , Zadeh, Gelareh , Jenkinson, Michael D. , Raleigh, David R. , Au, Karolyn , Barnhartz-Sloan, Jill, Butowski, N, Carlotti, Carlos Gilberto , Griffith, Brent, Hashizume, Rintaro , Hanemann, C. Oliver , Huang, Raymond Y. , Jungk, Christine, Kaufman, Timothy J, Krischek, Boris , Lee, Ian , Liu, Jeff C. , Mamatjan, Yasin , Mansouri, Alireza , Ng, Ho‐Keung , Pirouzmand, Farhad , Poisson, Laila , Pollo, Bianca , Sahm, Felix , Saladino, Andrea , Santarius, Thomas , Schichor, Christian , Selman, Warren R., Spears, Julian , Suppiah, Suganth , Tatagiba, Marcos, Tirapelli, Daniela, Tsang, Derek S. , Vogelbaum, Michael A. , Deimling, Andreas von , Walbert, Tobias , Westphal, Manfred , Workewych, Adriana M , Tatagiba, Marcos , Galanis, Evanthia , Mansouri, Alireza , von Deimling, Andreas , Sahm, Felix , Huang, Raymond , Lee, Ian Y , Herold‐Mende, Christel C. , McDermott, Michael , Tatagiba, Marcos , Tonn, Joerg-Christian , Wen, Patrick Yung , Bi, Wenya Linda , Cusimano, Michael D. , DiMeco, Francesco , Drummond, Katharine Jann , Giannini, Caterina , Horbinski, Craig , James, David, Jungk, Christine, Lachance, Daniel Honore , Fougère, Christian la , Muñoz, David G. , Noushmehr, Houtan , Perry, Arie , Schultz, David , Schmidt, Nils Ole , Hanemann, C Oliver , Mamatjan, Yasin

Mayo Clinic

Neuro-Oncology | September 17, 2018 | Volume: 21 | Issue: Supplement_1 | Pages: i18-i31

10.1093/neuonc/noy136 | PMID 30649489 Get It

Identifying Nuclear Matrix‐Attached DNA Across the Genome
Dobson, Jason R. , Hong, Deli , Wu, Hai , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , Wijnen, André J. van , Nickerson, Jeffrey A. , van Wijnen, Andre J, Barutcu, A. Rasim , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | September 14, 2016 | Volume: 232 | Issue: 6 | Pages: 1295-1305

10.1002/jcp.25596 | PMID 27627025 Get It

Experimental approaches to define the relationship between gene expression and nuclear matrix attachment regions (MARs) have given contrasting and method‐specific results. We have developed a next generation sequencing strategy to identify MARs across the human genome (MAR‐Seq). The method is based on crosslinking chromatin to its nuclear matrix attachment sites to minimize changes during biochemical processing. We used this method to compare nuclear matrix organization in MCF‐10A mammary epithelial‐like cells and MDA‐MB‐231 breast cancer cells and evaluated the results in the context of global gene expression (array analysis) and positional enrichment of gene‐regulatory histone modifications (ChIP‐Seq). In the normal‐like cells, nuclear matrix‐attached DNA was enriched in expressed genes, while in the breast cancer cells, it was enriched in non‐expressed genes. In both cell lines, the chromatin modifications that mark transcriptional activation or repression were appropriately associated with gene expression. Using this new MAR‐Seq approach, we provide the first genome‐wide characterization of nuclear matrix attachment in mammalian cells and reveal that the nuclear matrix‐associated genome is highly cell‐context dependent. J. Cell. Physiol. 232: 1295–1305, 2017. © 2016 Wiley Periodicals, Inc.
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation
Wu, Qiong , Madany, Pasil, Dobson, Jason R. , Schnabl, Jake , Sharma, Soni , Wijnen, André J. van , Stein, Janet L. , Lian, Jane B. , Stein, Gary S., Muthuswami, Rohini , Imbalzano, Anthony N. , Nickerson, Jeffrey A. , van Wijnen, Andre J, Smith, Tara C., van Wijnen, Andre J

Mayo Clinic

Oncotarget | May 21, 2016 | Volume: 7 | Issue: 25 | Pages: 38270-38281

10.18632/oncotarget.9505 | PMID 27223259 Get It

The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation
Wu, Qiong , Madany, Pasil, Akech, Jacqueline, Dobson, Jason R. , Douthwright, Stephen, Browne, Gillian , Colby, Jennifer L., Bradner, James E. , Pratap, Jitesh , Sluder, Greenfield, Chiosea, Simion I. , Wijnen, André J. van , Stein, Janet L. , Stein, Gary S., Lian, Jane B. , Nickerson, Jeffrey A. , Imbalzano, Anthony N. , van Wijnen, Andre J, Winter, Georg E. , Bhargava, Rohit , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | March 24, 2015 | Volume: 230 | Issue: 11 | Pages: 2683-2694

10.1002/jcp.24991 | PMID 25808524 Get It

The Brahma (BRM) and Brahma‐related Gene 1 (BRG1) ATPases are highly conserved homologs that catalyze the chromatin remodeling functions of the multi‐subunit human SWI/SNF chromatin remodeling enzymes in a mutually exclusive manner. SWI/SNF enzyme subunits are mutated or missing in many cancer types, but are overexpressed without apparent mutation in other cancers. Here, we report that both BRG1 and BRM are overexpressed in most primary breast cancers independent of the tumor's receptor status. Knockdown of either ATPase in a triple negative breast cancer cell line reduced tumor formation in vivo and cell proliferation in vitro. Fewer cells in S phase and an extended cell cycle progression time were observed without any indication of apoptosis, senescence, or alterations in migration or attachment properties. Combined knockdown of BRM and BRG1 showed additive effects in the reduction of cell proliferation and time required for completion of cell cycle, suggesting that these enzymes promote cell cycle progression through independent mechanisms. Knockout of BRG1 or BRM using CRISPR/Cas9 technology resulted in the loss of viability, consistent with a requirement for both enzymes in triple negative breast cancer cells. J. Cell. Physiol. 9999: 2683–2694, 2015. © 2015 Wiley Periodicals, Inc.